Chemical manufacturing company Genomatica has secured US$90m of equity investments following a drive to increase capital.
Participants include new lead investor
Not yet a Subscriber?
This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Cosmetics Business.
Subscribe now Already a subscriber? Sign in here.